Article | July 2, 2019

Managing Risks With Potent Pharmaceutical Products

Source: Pharmaceutics International

By Thomas Ingallinera, Vice President of Technical Support For Business Development

lab virtual science biologic bioprocess 450x300

As a noticeable shift occurs in the pharmaceutical industry from blockbuster drugs to smaller patient populations, there is an increased focus on targeted therapies in specialized areas, such as oncology, where potent compounds serve a key role in patient treatment. Any drug manufacturing facility handling these compounds must be equipped with the appropriate methods, controls, and expertise to ensure the safety of its employees and the integrity of its product. Managing these risks, though, requires a knowledgeable team as well as the design and implementation of an effective safety program.